Ur Metser, MD, FRCPC

Core Lead, Techna Institute for the Advancement of Technology for Health (Techna)

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Keywords: molecular imaging, magnetic resonance imaging (MRI), medical imaging, radiation therapy

Clinical applications of functional imaging in oncology
Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
Novel radiopharmaceuticals targeting tumors
Metabolic response assessment to therapy

Repeatability and reproducibility of MRI-based radiomic features in cervical cancer.

Radiother Oncol. 2019 Mar 19;135:107-114

Fiset S, Welch ML, Weiss J, Pintilie M, Conway JL, Milosevic M, Fyles A, Traverso A, Jaffray D, Metser U, Xie J, Han K

Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration.

Int J Gynecol Cancer. 2019 Mar 28;:

Kim SR, Lee YY, Brar H, Albert A, Covens A, Metser U, May T

The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.

J Nucl Med. 2019 Mar 22;:

Metser U, Chua SS, Ho B, Punwani S, Johnston E, Pouliot F, Tau N, Hawsawy A, Anconina R, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Pond G, Scott A, Tunariu N, Sidhu H, Emmett LM

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.

JCO Clin Cancer Inform. 2018 Dec;(2):1-12

Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL

Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.

JAMA Netw Open. 2018 Sep 07;1(5):e182081

Elit LM, Fyles AW, Gu CS, Pond GR, D'Souza D, Samant R, Anthes M, Thomas G, Filion M, Arsenault J, Dayes I, Whelan TJ, Gulenchyn KY, Metser U, Dhamanaskar K, Levine MN

Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.

Radiology. 2018 Dec 04;:181519

Metser U, Prica A, Hodgson DC, Mozuraitis M, Eberg M, Mak V, Green B, Singnurkar A, Dudebout J, MacCrostie P, Tau N, Mittmann N, Langer DL

A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance...

J Nucl Med. 2018 Nov 15;:

Emmett L, Metser U, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Punwani S, Pond GR, Chua SS, Ho B, Johnston E, Pouliot F, Scott A

Quantitative assessment of dynamic 18F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.

Br J Radiol. 2018 Nov 01;:20180568

Tau N, Berlin A, Yeung I, Halankar J, Murphy G, Jhaveri KS, Ghai S, Metser U

Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.

AJR Am J Roentgenol. 2018 Oct 17;:W1-W5

Metser U, Chan R, Veit-Haibach P, Ghai S, Tau N